Alpha Tau Medical (DRTSW) Accounts Payables (2020 - 2026)
Alpha Tau Medical (DRTSW) posted Accounts Payables of $3.7 million for Q1 2026, down 3.88% sequentially from $3.9 million in Q4 2025, and up 44.28% YoY from $2.6 million in Q1 2025.
Alpha Tau Medical (DRTSW) Accounts Payables (2020 - 2026) Analysis & Trends
Alpha Tau Medical has reported Accounts Payables for 7 years, with the latest figure at $3.7 million in Q1 2026.
- Quarterly Accounts Payables rose 44.28% year-over-year to $3.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.7 million (up 44.28% YoY) and the FY2025 annual result came in at $3.9 million, up 9.54% from the prior year.
- Accounts Payables declined to $3.7 million in Q1 2026 per DRTSW's latest filing, from $3.9 million in the prior quarter.
- Over five years, Accounts Payables peaked at $3.9 million in Q4 2025 and troughed at $1.2 million in Q2 2022.
- A 5-year average of $2.5 million and a median of $2.5 million in 2024 frame the typical range for Accounts Payables.
- The widest YoY moves for Accounts Payables: up 80.32% in 2023, down 45.99% in 2023.
- Over 5 years, Accounts Payables stood at $1.4 million in 2022, then jumped by 80.32% to $2.6 million in 2023, then jumped by 37.61% to $3.5 million in 2024, then climbed by 9.54% to $3.9 million in 2025, then dropped by 3.88% to $3.7 million in 2026.
- According to Business Quant data, Accounts Payables over the past three periods registered $3.7 million, $3.9 million, and $3.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 108.02 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 622.65 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 428.93 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 35.57 Mn |
| 10 | Alpha Tau Medical | 383.00 Mn | 200.58 Mn | - | 3.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.17 Mn |
| Mar 31, 2026 | 3.72 Mn |
| Dec 31, 2025 | 3.87 Mn |
| Sep 30, 2025 | 3.06 Mn |
| Jun 30, 2025 | 2.40 Mn |
| Mar 31, 2025 | 2.58 Mn |
| Dec 31, 2024 | 3.53 Mn |
| Sep 30, 2024 | 2.51 Mn |
| Jun 30, 2024 | 2.01 Mn |
| Mar 31, 2024 | 2.46 Mn |
| Dec 31, 2023 | 2.57 Mn |
| Sep 30, 2023 | 2.27 Mn |
| Jun 30, 2023 | 1.79 Mn |
| Mar 31, 2023 | 2.07 Mn |
| Dec 31, 2022 | 1.42 Mn |
| Sep 30, 2022 | 1.31 Mn |
| Jun 30, 2022 | 1.20 Mn |
| Mar 31, 2022 | 3.83 Mn |
| Dec 31, 2021 | 1.20 Mn |
| Dec 31, 2020 | 964,000.00 |